{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(23)"],"submitter":["Cuzzubbo S"],"pubmed_abstract":["We previously reported that a novel peptide vaccine platform, based on synthetic melanin nanoaggregates, triggers strong cytotoxic immune responses and significantly suppresses tumor growth in mice. However, the mechanisms underlying such an efficacy remained poorly described. Herein, we investigated the role of dendritic cells (DCs) in presenting the antigen embedded in the vaccine formulation, as well as the potential stimulatory effect of melanin upon these cells, in vitro by coculture experiments and ELISA/flow cytometry analysis. The vaccine efficiency was evaluated in FLT3-L-/- mice constitutively deficient in DC1, DC2, and pDCs, in Zbtb46DTR chimera mice deficient in DC1 and DC2, and in LangerinDTR mice deficient in dermal DC1 and Langerhans cells. We concluded that DCs, and especia"],"journal":["International journal of molecular sciences"],"pagination":["14975"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9738778"],"repository":["biostudies-literature"],"pubmed_title":["Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy."],"pmcid":["PMC9738778"],"pubmed_authors":["Tartour E","Vignal N","Hosten B","Banissi C","Carpentier AF","Leclercq M","Roch B","Cuzzubbo S","Darrasse-Jeze G"],"additional_accession":[]},"is_claimable":false,"name":"Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy.","description":"We previously reported that a novel peptide vaccine platform, based on synthetic melanin nanoaggregates, triggers strong cytotoxic immune responses and significantly suppresses tumor growth in mice. However, the mechanisms underlying such an efficacy remained poorly described. Herein, we investigated the role of dendritic cells (DCs) in presenting the antigen embedded in the vaccine formulation, as well as the potential stimulatory effect of melanin upon these cells, in vitro by coculture experiments and ELISA/flow cytometry analysis. The vaccine efficiency was evaluated in FLT3-L-/- mice constitutively deficient in DC1, DC2, and pDCs, in Zbtb46DTR chimera mice deficient in DC1 and DC2, and in LangerinDTR mice deficient in dermal DC1 and Langerhans cells. We concluded that DCs, and especia","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-20T03:34:26.352Z","creation":"2025-04-20T03:34:26.352Z"},"accession":"S-EPMC9738778","cross_references":{"pubmed":["36499300"],"doi":["10.3390/ijms232314975"]}}